Harvest Fund Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96K Sell
451
-12
-3% -$2.35K ﹤0.01% 300
2026
Q1
$91K Buy
463
+361
+354% +$70.1K ﹤0.01% 313
2025
Q4
$18K Hold
102
﹤0.01% 478
2025
Q3
$19K Sell
102
-201
-66% -$35.7K ﹤0.01% 502
2025
Q2
$54K Sell
303
-4,741
-94% -$823K ﹤0.01% 426
2025
Q1
$854K Buy
5,044
+2,333
+86% +$383K 0.04% 213
2024
Q4
$409K Buy
+2,711
New +$422K 0.02% 362
2023
Q1
Sell
-128
Closed -$20K 759
2022
Q4
$20K Hold
128
0.01% 590
2022
Q3
$16K Hold
128
﹤0.01% 577
2022
Q2
$17K Hold
128
﹤0.01% 554
2022
Q1
$17K Sell
128
-362
-74% -$50.5K ﹤0.01% 593
2021
Q4
$84K Buy
490
+392
+400% +$59.6K 0.01% 367
2021
Q3
$14K Hold
98
﹤0.01% 652
2021
Q2
$13K Hold
98
﹤0.01% 696
2021
Q1
$12K Sell
98
-270
-73% -$33.3K ﹤0.01% 736
2020
Q4
$43K Hold
368
﹤0.01% 381
2020
Q3
$42K Sell
368
-366
-50% -$43.2K ﹤0.01% 417
2020
Q2
$83K Sell
734
-947
-56% -$100K 0.01% 263
2020
Q1
$134K Buy
+1,681
New +$174K 0.02% 161
2019
Q4
Sell
-503
Closed -$54K 427
2019
Q3
$54K Sell
503
-359
-42% -$36.9K 0.01% 265
2019
Q2
$88K Buy
+862
New +$82.8K 0.01% 222
2018
Q1
Sell
-450
Closed -$44K 238
2017
Q4
$44K Hold
450
0.01% 185
2017
Q3
$42K Hold
450
0.01% 164
2017
Q2
$50K Hold
450
0.01% 153
2017
Q1
$44K Hold
450
0.01% 161
2016
Q4
$41K Buy
+450
New +$38.8K 0.01% 170

Other funds holding DGX

Harvest Fund Management's DGX Position: Q2 2026 in Review

Harvest Fund Management reduced its Quest Diagnostics (DGX) stake by 2.6% in Q2 2026, selling an estimated $2.35K and leaving 451 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

Harvest Fund Management first reported a position in DGX in Q4 2016 and has held it in 26 quarters since. The position peaked at $854K in Q1 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Harvest Fund Management held 451 shares of Quest Diagnostics worth $96K as of Q2 2026.
  • Harvest Fund Management sold 12 Quest Diagnostics shares in Q2 2026, an estimated $2.35K.
  • Quest Diagnostics made up ﹤0.01% of Harvest Fund Management's portfolio in Q2 2026, its #300 holding.
  • Harvest Fund Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 26 quarters since.
  • Harvest Fund Management's Quest Diagnostics position peaked at $854K in Q1 2025.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.